• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Oestrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patients.乳腺肿瘤中的雌激素受体:735例患者中与年龄、绝经状态以及流行病学和临床特征的关联
Br J Cancer. 1980 Nov;42(5):635-44. doi: 10.1038/bjc.1980.296.
2
Risk factors and clinical data related to oestrogen receptor status in women presenting with breast cancer.
Br J Surg. 1985 Aug;72(8):629-33. doi: 10.1002/bjs.1800720815.
3
Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study.按雌激素受体状态分类的乳腺癌危险因素:一项基于人群的病例对照研究。
Br J Cancer. 1989 Jan;59(1):119-25. doi: 10.1038/bjc.1989.24.
4
The incidence of positive oestrogen and progesterone receptors in breast cancer of Greek women.
Anticancer Res. 1981;1(4):195-7.
5
Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.人乳腺癌中雌激素、孕激素、雄激素和糖皮质激素受体的分布、频率及定量分析。
Cancer Res. 1979 May;39(5):1447-54.
6
Relationship between oestrogen-receptor content and histological grade in human primary breast tumours.人类原发性乳腺肿瘤中雌激素受体含量与组织学分级之间的关系。
Br J Cancer. 1978 Dec;38(6):745-8. doi: 10.1038/bjc.1978.282.
7
Relationship of oestrogen-receptor status to survival in breast cancer.
Lancet. 1979 Aug 11;2(8137):283-4. doi: 10.1016/s0140-6736(79)90295-2.
8
Estrogen receptor status of breast cancer in Ontario.安大略省乳腺癌的雌激素受体状态
CMAJ. 1985 Nov 15;133(10):997-1000.
9
An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint).一项关于已确定的乳腺癌生殖和生活方式风险因素与由预后70基因表达特征(MammaPrint)定义的肿瘤亚型的关联研究。
Eur J Cancer. 2017 Apr;75:5-13. doi: 10.1016/j.ejca.2016.12.024. Epub 2017 Feb 16.
10
A correlation between oestrogen receptors and tumour size in primary breast cancer.原发性乳腺癌中雌激素受体与肿瘤大小之间的相关性。
Eur J Surg Oncol. 1985 Dec;11(4):357-60.

引用本文的文献

1
Uterine Malignant Mixed Müllerian Tumors Following Treatment with Selective Estrogen Receptor Modulators in Patients with Breast Cancer: A Report of 13 Cases and Their Clinicopathologic Characteristics.乳腺癌患者接受选择性雌激素受体调节剂治疗后发生的子宫恶性混合性苗勒管肿瘤:13例报告及其临床病理特征
J Pathol Transl Med. 2019 Jan;53(1):31-39. doi: 10.4132/jptm.2018.11.16. Epub 2018 Dec 18.
2
Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.乳腺癌中雌激素和孕激素受体的免疫组织化学测定:与科特迪瓦302例患者临床病理因素的关系
BMC Cancer. 2017 Feb 7;17(1):115. doi: 10.1186/s12885-017-3105-z.
3
The molecular landscape of premenopausal breast cancer.绝经前乳腺癌的分子格局
Breast Cancer Res. 2015 Aug 7;17:104. doi: 10.1186/s13058-015-0618-8.
4
Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women.白人女性和黑人女性中雌激素受体表达与乳腺癌特异性死亡风险的定量测量。
Breast Cancer Res. 2013;15(5):R90. doi: 10.1186/bcr3486.
5
Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison.按雌激素和孕激素受体状态划分的50岁以下女性乳腺癌的激素相关危险因素:病例对照研究和病例-病例比较结果
Breast Cancer Res. 2006;8(4):R39. doi: 10.1186/bcr1514.
6
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients.细胞周期蛋白D1过表达是绝经后乳腺癌患者对他莫昔芬反应的负性预测因子。
Br J Cancer. 2004 May 17;90(10):1942-8. doi: 10.1038/sj.bjc.6601831.
7
A hospital-based case-control study of breast-cancer risk factors by estrogen and progesterone receptor status.一项基于医院的、按雌激素和孕激素受体状态分组的乳腺癌危险因素病例对照研究。
Cancer Causes Control. 1993 Jan;4(1):39-44. doi: 10.1007/BF00051712.
8
Breast cancer in the elderly.老年乳腺癌
Postgrad Med J. 1995 Nov;71(841):658-64. doi: 10.1136/pgmj.71.841.658.
9
Review of general surgery 1980.普通外科学综述,1980年。
Postgrad Med J. 1981 Jun;57(668):341-57. doi: 10.1136/pgmj.57.668.341.
10
Estrogen and progesterone receptor profile patterns in primary breast cancer.原发性乳腺癌中的雌激素和孕激素受体谱模式
Breast Cancer Res Treat. 1983;3(1):103-10. doi: 10.1007/BF01806241.

本文引用的文献

1
Statistical aspects of the analysis of data from retrospective studies of disease.疾病回顾性研究数据的统计分析方面
J Natl Cancer Inst. 1959 Apr;22(4):719-48.
2
Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.雌激素受体作为乳腺癌早期复发的独立预后因素。
Cancer Res. 1977 Dec;37(12):4669-71.
3
Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication.
Cancer. 1977 Nov;40(5):2290-8. doi: 10.1002/1097-0142(197711)40:5<2290::aid-cncr2820400541>3.0.co;2-t.
4
An improved assay for nuclear estrogen receptor in experimental and human breast cancer.一种用于实验性和人类乳腺癌中核雌激素受体的改良检测方法。
Cancer Res. 1977 Sep;37(9):3333-7.
5
Estrogen receptor and endocrine responsiveness in Japanese versus American breast cancer patients.日本与美国乳腺癌患者的雌激素受体及内分泌反应性
Cancer Res. 1977 Jan;37(1):106-10.
6
Oestrogen receptors and peripheral serum levels of oestradiol-17beta in patients with mammary carcinoma.乳腺癌患者的雌激素受体及外周血雌二醇-17β水平
Eur J Cancer (1965). 1978 Dec;14(12):1337-40. doi: 10.1016/0014-2964(78)90115-9.
7
Hormone receptors: their role in predicting prognosis and response to endocrine therapy.
Semin Oncol. 1978 Dec;5(4):428-33.
8
Increased incidence of positive tests for estrogen binding in mammary carcinoma specimens transported in liquid nitrogen.在液氮中运输的乳腺癌标本中,雌激素结合阳性检测的发生率增加。
Am J Clin Pathol. 1978 Nov;70(5):780-2. doi: 10.1093/ajcp/70.5.780.
9
Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer.
N Engl J Med. 1978 Dec 14;299(24):1330-4. doi: 10.1056/NEJM197812142992403.
10
Estrogen receptor assay of carcinomas of the breast by a simplified dextran--charcoal method.
Am J Clin Pathol. 1978 Oct;70(4):655-64. doi: 10.1093/ajcp/70.4.655.

乳腺肿瘤中的雌激素受体:735例患者中与年龄、绝经状态以及流行病学和临床特征的关联

Oestrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patients.

作者信息

Elwood J M, Godolphin W

出版信息

Br J Cancer. 1980 Nov;42(5):635-44. doi: 10.1038/bjc.1980.296.

DOI:10.1038/bjc.1980.296
PMID:7459204
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2010532/
Abstract

Comparisons between oestrogen-receptor (RE)-positive or negative patients were made on a continuous series of 735 patients with primary breast tumours seen at the major treatment centre in British Columbia between 1975 and 1978. RE positivity was commoner in older patients, and was not associated with menopausal status independently of age. The concentration of receptor protein also increased with increasing age, but was not affected by menopausal status. Neither RE status nor quantity was associated with any of the epidemiological risk factors studied, which included parity, age at first birth, weight, family history and exposure to oestrogenic drugs and oral contraceptives. Patients with RE- tumours were more likely to present with symptoms other than a breast lump, pain or nipple inversion, and had less-differentiated tumours; they did not differ from RE+ patients in terms of stage, size of tumour, or interval from first symptom. These findings are discussed in terms of the biological origin and determinants of oestrogen receptors.

摘要

对1975年至1978年间在不列颠哥伦比亚省主要治疗中心就诊的735例原发性乳腺肿瘤患者进行了连续研究,比较了雌激素受体(ER)阳性和阴性患者的情况。ER阳性在老年患者中更为常见,且与绝经状态无关,独立于年龄因素。受体蛋白的浓度也随年龄增长而增加,但不受绝经状态影响。ER状态和数量均与所研究的任何流行病学危险因素无关,这些因素包括产次、初产年龄、体重、家族史以及接触雌激素药物和口服避孕药。ER阴性肿瘤患者比ER阳性患者更易出现除乳房肿块、疼痛或乳头内陷以外的症状,且肿瘤分化程度较低;在分期、肿瘤大小或从首发症状开始的时间间隔方面,他们与ER阳性患者没有差异。本文从雌激素受体的生物学起源和决定因素方面对这些发现进行了讨论。